Evaluation of single nucleotide polymorphisms of BRCA1, CDKN1A, TP53BP, and XRCC1 in multiple myeloma patients undergoing hematopoietic stem cells transplant and their association with clinical outcomes

Basic Information

Funding Cycle : 2021-2022
Name : David Garrido
Type of Award : Career Development Award
Home Institution : Hospital de Clínicas "Dr. Manuel Quintela", Uruguay
Host Institution : Institute of Experimental Medicine, CONICET-Academia Nacional de Medicina, Buenos Aires, Argentina


ipsum lorem

Why Become a Member

The International Myeloma Society is a professional, scientific, and medical society established to bring together clinical and experimental scientists involved in the study of myeloma. The purpose of this society is to promote research, education, clinical studies (including diagnosis and treatment), workshops, conferences, and symposia on all aspects of multiple myeloma worldwide.

The IMS is a membership organization comprised of basic research scientists, and clinical investigators in the field along with physicians and other healthcare practitioners.

Stay updated on our Events